Berry Global Healthcare will display various pharmaceutical packaging solutions at Pharmapack 2024, including a new dry powder inhaler for combination drugs; an ophthalmic nozzle designed for safe and reliable administration; and a child-resistant closure featuring digital technology for improved medication adherence.
Attendees are encouraged to visit Berry’s stand to view the Pneumohaler, a breath-actuated multidose inhaler dose counter designed as a lightweight solution to control and treat asthma and chronic obstructive pulmonary disease (COPD).
Alongside it, a patented ophthalmic nozzle for drug delivery, Risdrop, will be displayed. It is designed for the precise application of drugs to exact locations on the eye and prioritizes safety, consistency, and reliability.
Meanwhile, the Berry Digi-Cap is a child-resistant closure featuring digital technology in a bid to improve the adherence of medication.
The BerryHaler will also be launched at the exhibition. This is an all-plastic, dual-chamber dry powder inhaler intended to store two separate medications for subsequent, simultaneous inhalation.
Additionally, the fully integrated CDMO service will be showcased as a complete end-to-end solution for Berry customers. Its capabilities are said to range from product conceptualization to manufacturing and final packaging – increasing speed to market of customized drug delivery products to meet customer and healthcare requirements.
Each product is designed to align with Berry’s Dose Better initiative, which sets its sights on packaging and drug delivery devices that put patients at the forefront by improving dosing, administration, and medication adherence.
As part of Pharmapack’s events programme, Berry will present a sustainability workshop – Achieving More Together: How Collaborative Action Drives Innovation and Circularity in Healthcare Packaging – on the first day of the exhibition. It will focus on the packaging and medical device specifications faced by pharmaceutical companies; and how companies can set practical strategies to pursue patient well-being and environmental sustainability simultaneously.
Alan Quemeneur, VP Sales, Business Development and R&D, Berry Global Healthcare, said: “Pharmapack provides the perfect opportunity for pharmaceutical professionals to learn about the latest developments in packaging and drug delivery solutions.
“Our Dose Better initiative is focused on working with our consumer and pharmaceutical healthcare customers to improve adherence, administration, and safety. Berry’s Global Healthcare unit is relentlessly committed to creating innovative solutions and services that better the patient experience. We look forward to sharing our latest innovations with visitors.”
In another display of progress in the pharmaceutical sector, Coveris previewed its medical packaging solutions at the COMPAMED show in Düsseldorf. The range sought to minimize packaging and product waste without sacrificing the functionality and safety of conventional materials.
Amcor has also revealed a mono-PE laminate designed for all-film medical packaging; it can apparently be recycled in the polyethylene stream to lower a pack’s carbon footprint while maintaining patient safety.
If you liked this article, you might also enjoy:
The Lidl approach to packaging sustainability
How did Brazil achieve its 100% aluminium can recycling rate – and can it be replicated in the EU?
Experts have their say on the EU’s Packaging and Packaging Waste Directive revisions
A deep dive into the most important packaging sustainability trends and solutions
No comments yet